Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials
about
The ubiquitin proteasomal system: a potential target for the management of Alzheimer's diseaseAn overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsProteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's DiseaseTau Biology and Tau-Directed Therapies for Alzheimer's DiseasePreclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer's DiseaseMonoaminergic neuropathology in Alzheimer's disease.Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals.Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs.Amyloid beta: structure, biology and structure-based therapeutic development.Familial Alzheimer's disease-associated presenilin 1 mutants promote γ-secretase cleavage of STIM1 to impair store-operated Ca2+ entry.Ethanolic extract of Streblus asper leaves protects against glutamate-induced toxicity in HT22 hippocampal neuronal cells and extends lifespan of Caenorhabditis elegans.PSD-93 Attenuates Amyloid-β-Mediated Cognitive Dysfunction by Promoting the Catabolism of Amyloid-β.Simvastatin inhibits the apoptosis of hippocampal cells in a mouse model of Alzheimer's disease.The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer's Disease.Genome instability in Alzheimer disease.
P2860
Q26749321-8FF057D9-2FA0-467E-A2B1-815DE078EE96Q26751302-CC635AB2-64C8-4586-8D19-E172B49728D4Q26777933-6992E590-1872-4DDA-8FE3-84F0A4C6506FQ28071398-ED2175A3-CDBE-4D13-8DB3-F551C2E015CEQ36939748-E318C33E-8E2B-46FD-AF9A-81743ABBBA0AQ38809649-EEFE01C5-7E67-4469-8637-2F07E8E7DA7EQ38826557-E46C179E-C5F3-4984-B95A-DFF2F989C99FQ38942195-AC4B33D8-C36F-4C25-831A-EBE80F5A9CF0Q39313818-CCE56190-17A3-4C70-9820-0077F589F7E9Q39437881-30EE8EB5-4011-4346-A256-F358D536E0D7Q42078669-973D3653-2C9D-4260-80DB-05AB41159DACQ47141490-07A6BE8B-C050-4239-9B3B-51ADA4208943Q47975756-AB7C7205-C1B3-4BF9-95B9-474447C2B51DQ49747183-86479313-F44F-4E98-AB6B-B8D68C10BD0FQ49958991-12139EE5-3E90-4A27-8E51-9EE657E4EA1DQ53116855-232AACBB-A121-4E84-840C-D986A5DE160F
P2860
Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Potential therapeutic strategi ...... insights from clinical trials
@ast
Potential therapeutic strategi ...... insights from clinical trials
@en
Potential therapeutic strategi ...... insights from clinical trials
@nl
type
label
Potential therapeutic strategi ...... insights from clinical trials
@ast
Potential therapeutic strategi ...... insights from clinical trials
@en
Potential therapeutic strategi ...... insights from clinical trials
@nl
prefLabel
Potential therapeutic strategi ...... insights from clinical trials
@ast
Potential therapeutic strategi ...... insights from clinical trials
@en
Potential therapeutic strategi ...... insights from clinical trials
@nl
P2860
P921
P356
P1476
Potential therapeutic strategi ...... insights from clinical trials
@en
P2093
Qiutian Jia
P2860
P304
P356
10.1155/2014/837157
P407
P50
P5008
P577
2014-07-17T00:00:00Z